Neuphoria Therapeutics (NEUP) vs Radiopharm Theranostics (RADX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Neuphoria Therapeutics (NEUP) has outperformed Radiopharm Theranostics (RADX) over the past year, losing 81.8% versus a loss of 83.7%. Neuphoria Therapeutics is the larger company by market cap ($18.4 million vs $16.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NEUP | RADX |
|---|---|---|
| Share price | $3.41 | $1.11 |
| Market cap | $18.43M | $16.20M |
| 1-day change | -0.44% | -3.48% |
| YTD return | -11.86% | -77.97% |
| 1-year return | -81.78% | -83.66% |
| EPS (TTM) | $-3.06 | $-3.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.21 | $16.25 |
| 52-week low | $3.19 | $1.00 |
| Distance from 52-week high | -82.27% | -93.17% |
| Average volume | 162.11K | 84.62K |
| Shares outstanding | 5.41M | 14.59M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
NEUP vs RADX FAQ
Which is bigger, Neuphoria Therapeutics or Radiopharm Theranostics?
Neuphoria Therapeutics (NEUP) is larger, with a market capitalization of $18.43M compared with $16.20M for Radiopharm Theranostics (RADX).
Which stock has performed better over the past year, NEUP or RADX?
NEUP returned -81.78% over the past 12 months, compared with -83.66% for RADX (price return, excluding dividends). Past performance does not predict future results.
Are Neuphoria Therapeutics and Radiopharm Theranostics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.